Clinical Trial Update: Study of TN-001 Topical Eyedrops for Keratoconus [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates TN-001 topical eyedrops for keratoconus are in Phase 1/2 and currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• TN-001 Topical Eyedrops (TN-001)

Snippet

Sponsor: TheiaNova Ltd. | Conditions: Keratoconus | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION